2024-11-01 2025-10-31 false Capium Accounts Production 1.1 13670603 2024-11-01 2025-10-31 13670603 bus:AbridgedAccounts 2024-11-01 2025-10-31 13670603 bus:FRS102 2024-11-01 2025-10-31 13670603 bus:AuditExemptWithAccountantsReport 2024-11-01 2025-10-31 13670603 bus:SmallCompaniesRegimeForAccounts 2024-11-01 2025-10-31 13670603 bus:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 13670603 2024-11-01 2025-10-31 13670603 2025-10-31 13670603 bus:RegisteredOffice 2024-11-01 2025-10-31 13670603 core:WithinOneYear 2025-10-31 13670603 core:AfterOneYear 2025-10-31 13670603 1 2024-11-01 2025-10-31 13670603 bus:Director1 2024-11-01 2025-10-31 13670603 bus:Director1 2025-10-31 13670603 bus:Director1 2023-11-01 2024-10-31 13670603 2023-11-01 13670603 bus:LeadAgentIfApplicable 2024-11-01 2025-10-31 13670603 2023-11-01 2024-10-31 13670603 2024-10-31 13670603 core:WithinOneYear 2024-10-31 13670603 core:AfterOneYear 2024-10-31 13670603 bus:EntityAccountantsOrAuditors 2023-11-01 2024-10-31 13670603 bus:OrdinaryShareClass1 2024-11-01 2025-10-31 13670603 bus:OrdinaryShareClass1 2025-10-31 13670603 bus:OrdinaryShareClass1 2023-11-01 2024-10-31 13670603 bus:OrdinaryShareClass1 2024-10-31 13670603 core:CostValuation core:Non-currentFinancialInstruments 2025-10-31 13670603 core:CostValuation core:Non-currentFinancialInstruments 2024-10-31 13670603 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-10-31 13670603 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-10-31 13670603 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-10-31 13670603 core:Non-currentFinancialInstruments 2025-10-31 13670603 core:Non-currentFinancialInstruments 2024-10-31 13670603 core:ShareCapital 2025-10-31 13670603 core:ShareCapital 2024-10-31 13670603 core:RetainedEarningsAccumulatedLosses 2025-10-31 13670603 core:RetainedEarningsAccumulatedLosses 2024-10-31 13670603 dpl:Item1 2024-11-01 13670603 dpl:Item1 2025-10-31 13670603 dpl:Item1 2023-11-01 13670603 dpl:Item1 2024-10-31 iso4217:GBP xbrli:shares xbrli:pure
Reports Dated : 29/07/2026 Registered Number: 13670603
England and Wales

 

 

 

ESTIEB HEALTH & BEAUTY WORLD LTD



Abridged Accounts
 


Period of accounts

Start date: 01 November 2024

End date: 31 October 2025

ESTIEB HEALTH & BEAUTY WORLD LTD
Contents Page
For the year ended 31 October 2025
In order to assist you to fulfil your duties under Companies Act 2006, we have prepared for your approval the accounts of ESTIEB HEALTH & BEAUTY WORLD LTD for the year ended 31 October 2025 which comprise the Statement of Comprehensive Income, the Statement of Financial Position, the Statement of Changes in Equity and related notes from the company's accounting records and from information and explanations you have given us. This report is made solely to the member of ESTIEB HEALTH & BEAUTY WORLD LTD, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the accounts of ESTIEB HEALTH & BEAUTY WORLD LTD and state those matters that we have agreed to state to the Board of ESTIEB HEALTH & BEAUTY WORLD LTD, as a body in this report. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than ESTIEB HEALTH & BEAUTY WORLD LTD and its members as a body for our work or for this report.

It is your duty to ensure that ESTIEB HEALTH & BEAUTY WORLD LTD has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and Profit of ESTIEB HEALTH & BEAUTY WORLD LTD. You consider that ESTIEB HEALTH & BEAUTY WORLD LTD is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the accounts of ESTIEB HEALTH & BEAUTY WORLD LTD. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.



....................................................

VICTOR CHANCE LIMITED
( Chartered Certified Accountants)
1 Blueberry Avenue
Manchester
M40 0GE
29 July 2026
1
 
 		 Notes
 		 2025
£		   2024
£
Current assets      
Cash at bank and in hand 10,175    6,051 
Creditors: amount falling due within one year (3,838)   (3,307)
Net current assets 6,337    2,744 
 
Total assets less current liabilities 6,337    2,744 
Net assets 6,337    2,744 
 

Capital and reserves 		     
Called up share capital 3 1    1 
Profit and loss account 6,336    2,743 
Shareholders' funds 6,337    2,744 
 


For the year ended 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the director on 29 July 2026 and were signed by:


-------------------------------
Esther Abosede Oyeleye
Director
2
General Information
ESTIEB HEALTH & BEAUTY WORLD LTD is a private limited company, registered in England & Wales, registration number 13670603, registration address 793 Moston Lane , Manchester , M40 5RJ.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.

Basis of preparation
The financial statements have been prepared under the historical cost convention.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of trade discounts.
Taxation
The companys liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Dividends
 A total dividend sums of £10,000 was paid to the shareholder in the year
2.

Average number of employees

Average number of employees during the year was 1 (2024 : 1).
3.

Share Capital

Authorised
1 Class A share of £1.00 each
Allotted, called up and fully paid
2025
£		   2024
£
1 Class A share of £1.00 each 1    1 
1    1 

3